ClinVar Miner

Submissions for variant NM_000051.4(ATM):c.5419A>C (p.Lys1807Gln)

dbSNP: rs1591712583
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001024071 SCV001186027 uncertain significance Hereditary cancer-predisposing syndrome 2019-07-29 criteria provided, single submitter clinical testing The p.K1807Q variant (also known as c.5419A>C), located in coding exon 35 of the ATM gene, results from an A to C substitution at nucleotide position 5419. The lysine at codon 1807 is replaced by glutamine, an amino acid with similar properties. While this exact alteration has not been reported in the literature, a similar alteration at the same position, c.5419A>G, has been shown to result in reduced ATM kinase activity (Barone G et al. Hum. Mutat. 2009 Aug;30(8):1222-30). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.